IOPAMIDOL-200 IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Iopamidol-200 In Plastic Container patents expire, and when can generic versions of Iopamidol-200 In Plastic Container launch?
Iopamidol-200 In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in IOPAMIDOL-200 IN PLASTIC CONTAINER is iopamidol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iopamidol-200 In Plastic Container
A generic version of IOPAMIDOL-200 IN PLASTIC CONTAINER was approved as iopamidol by HAINAN POLY on February 27th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IOPAMIDOL-200 IN PLASTIC CONTAINER?
- What are the global sales for IOPAMIDOL-200 IN PLASTIC CONTAINER?
- What is Average Wholesale Price for IOPAMIDOL-200 IN PLASTIC CONTAINER?
Summary for IOPAMIDOL-200 IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 26 |
| Patent Applications: | 4,643 |
| DailyMed Link: | IOPAMIDOL-200 IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for IOPAMIDOL-200 IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Masonic Cancer Center, University of Minnesota | PHASE2 |
| National Cancer Institute (NCI) | PHASE2 |
| Chongqing Emergency Medical Center | N/A |
US Patents and Regulatory Information for IOPAMIDOL-200 IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | IOPAMIDOL-200 IN PLASTIC CONTAINER | iopamidol | INJECTABLE;INJECTION | 074636-001 | Dec 30, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
